STRO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STRO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Sutro Biopharma's Degree of Operating Leverage for the quarter that ended in Dec. 2024 was -3.34. The higher Degree of Operating Leverage, the higher operating risk the company will take.
The industry rank for Sutro Biopharma's Degree of Operating Leverage or its related term are showing as below:
The historical data trend for Sutro Biopharma's Degree of Operating Leverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sutro Biopharma Annual Data | |||||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||||||
Degree of Operating Leverage | Get a 7-Day Free Trial |
![]() |
1,386.47 | 5.91 | 1.12 | -0.34 | -3.34 |
Sutro Biopharma Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Degree of Operating Leverage | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.34 | -0.42 | -0.24 | -0.23 | -3.34 |
For the Biotechnology subindustry, Sutro Biopharma's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Sutro Biopharma's Degree of Operating Leverage distribution charts can be found below:
* The bar in red indicates where Sutro Biopharma's Degree of Operating Leverage falls into.
Sutro Biopharma's Degree of Operating Leverage for the quarter that ended in Dec. 2024 is calculated as:
Degree of Operating Leverage | = | % Change in EBIT** | / | % Change in Revenue |
= | ( -194.028 (Dec. 2024) / -64.851 (Dec. 2023) - 1 ) | / | ( 62.043 (Dec. 2024) / 153.731 (Dec. 2023) - 1 ) | |
= | 1.9919 | / | -0.5964 | |
= | -3.34*** |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sutro Biopharma (NAS:STRO) Degree of Operating Leverage Explanation
Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.
A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.
Be Aware
The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.
Thank you for viewing the detailed overview of Sutro Biopharma's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.
Nicki Vasquez | officer: Chief Port. Strat & Alnce Ofcr | C/O SUTRO BIOPHARMA, INC., 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO CA 94080 |
Hans-peter Gerber | officer: Chief Scientific Officer | C/O SUTRO BIOPHARMA, INC., 111 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080 |
Brunilda Shtylla | officer: Chief Business Officer | C/O SUTRO BIOPHARMA, INC., 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO CA 94080 |
Venkatesh Srinivasan | officer: Chief Tech Op Officer | C/O SUTRO BIOPHARMA, INC., 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO CA 94080 |
Anne Elizabeth Borgman | officer: Chief Medical Officer | 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE MD 20705 |
William J Newell | director, officer: CEO & President | 887 GREAT NORTHERN WAY, VANCOUVER A1 V5T 4T5 |
Heidi Hunter | director | C/O SUTRO BIOPHARMA, INC., 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO CA 94080 |
Jane Chung | officer: Chief Commercial Officer | C/O SUTRO BIOPHARMA, INC., 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO CA 94080 |
Trevor Hallam | officer: Chief Science Officer | PALATIN TECHNOLOGIES, INC., 4C CEDAR BROOK DRIVE, CRANBURY NJ 08512 |
Jon Marc Wigginton | director | 9640 MEDICAL CENTER DRIVE, ROCKVILLE MD 20850 |
John Gordon Freund | director, 10 percent owner | 125 UNIVERSITY AVE., C/O SKYLINE VENTURES, PALO ALTO CA 94301 |
Arturo Md Molina | officer: Chief Medical Officer | 10990 WILSHIRE BLVD, SUITE 1200, LOS ANGELES CA 90024 |
Linda A Fitzpatrick | officer: Chief People & Comm. Officer | NUVELO, INC., 675 ALMANOR AVENUE, SUNNYVALE CA 94085 |
James P Panek | director | C/O VAXGEN INC, 1000 MARINA BLVD. #200, BRISBANE CA 94005 |
Matsui Connie | director | 3030 CALLAN RD, SAN DIEGO CA 92121 |
From GuruFocus
By Marketwired • 03-13-2025
By GuruFocus News • 03-14-2025
By Marketwired • 08-22-2024
By GuruFocus Research • 02-09-2024
By GuruFocus News • 03-14-2025
By Marketwired • 03-15-2025
By Marketwired • 01-07-2025
By Marketwired • 08-13-2024
By Marketwired • 09-14-2024
By Marketwired • 03-03-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.